SOD1 and metabolic dysfunction-associated steatohepatitis: Surprisingly, some studies reveal a marked decrease in serum or hepatic SOD activity in patients suffering from MASH as compared to healthy controls (Koruk et al. 2004; Videla et al. 2004).